Photooxidation Mechanism of Levomepromazine in Different Solvents. (10th September 2013)
- Record Type:
- Journal Article
- Title:
- Photooxidation Mechanism of Levomepromazine in Different Solvents. (10th September 2013)
- Main Title:
- Photooxidation Mechanism of Levomepromazine in Different Solvents
- Authors:
- Piñero‐Santiago, Luis E.
García, Carmelo
Lhiaubet‐Vallet, Virginie
Trzcionka, Jerome
Oyola, Rolando
Torres, Karen
Leguillú, Jaysika
Miranda, Miguel A. - Abstract:
- Abstract: Unwanted photoinduced responses are well‐known adverse effects of most promazine drugs, including levomepromazine (LPZ, Levoprome ® or Nozinan ® ). This drug is indicated in psychiatry primarily for the treatment of schizophrenia and other schizoaffective disorders. Levomepromazine's particular sedative properties make it especially fit for use in psychiatric intensive care. Nevertheless, it is photolabile under UV‐A and UV‐B light in aerobic conditions resulting in the formation of its sulfoxide. The LPZ photochemistry in acetonitrile (MeCN) is completely different from that in methanol (MeOH) and phosphate buffer solutions (PBS, pH = 7.4). The major photoproduct in PBS and MeOH under aerobic conditions is levomepromazine sulfoxide (LPZSO), although the amount is considerably higher in the aqueous environment. The corresponding main photoproduct in MeCN could not be characterized. The destruction quantum yields of LPZ in PBS, MeOH and MeCN are 0.13, 0.02 and <10 −3, respectively. It is further demonstrated that LPZSO does not form by the reaction of singlet oxygen with ground‐state LPZ. This oxidation product is actually produced by the reaction of the cation radical of LPZ (LPZ· + ) with molecular oxygen. This cation radical in turn, is produced by an electron transfer process between the 3 LPZ* and ground‐state molecular oxygen. Abstract : Levomepromazine (LPZ, Levoprome ® or Nozinan ® ) is indicated for the treatment of schizophrenia and other schizoaffectiveAbstract: Unwanted photoinduced responses are well‐known adverse effects of most promazine drugs, including levomepromazine (LPZ, Levoprome ® or Nozinan ® ). This drug is indicated in psychiatry primarily for the treatment of schizophrenia and other schizoaffective disorders. Levomepromazine's particular sedative properties make it especially fit for use in psychiatric intensive care. Nevertheless, it is photolabile under UV‐A and UV‐B light in aerobic conditions resulting in the formation of its sulfoxide. The LPZ photochemistry in acetonitrile (MeCN) is completely different from that in methanol (MeOH) and phosphate buffer solutions (PBS, pH = 7.4). The major photoproduct in PBS and MeOH under aerobic conditions is levomepromazine sulfoxide (LPZSO), although the amount is considerably higher in the aqueous environment. The corresponding main photoproduct in MeCN could not be characterized. The destruction quantum yields of LPZ in PBS, MeOH and MeCN are 0.13, 0.02 and <10 −3, respectively. It is further demonstrated that LPZSO does not form by the reaction of singlet oxygen with ground‐state LPZ. This oxidation product is actually produced by the reaction of the cation radical of LPZ (LPZ· + ) with molecular oxygen. This cation radical in turn, is produced by an electron transfer process between the 3 LPZ* and ground‐state molecular oxygen. Abstract : Levomepromazine (LPZ, Levoprome ® or Nozinan ® ) is indicated for the treatment of schizophrenia and other schizoaffective disorders. Nevertheless, it is photolabile under UV‐A and UV‐B light in aerobic conditions resulting in the formation of its sulfoxide (LPZO). LPZSO does not form by the reaction of singlet oxygen with ground state LPZ. This oxidation product is actually produced by the reaction of the cation radical of LPZ (LPZ· + ) with molecular oxygen. This cation radical in turn, is produced by an electron transfer process between the 3 LPZ* and ground state molecular oxygen. … (more)
- Is Part Of:
- Photochemistry and photobiology. Volume 89:Number 6(2013:Nov./Dec.)
- Journal:
- Photochemistry and photobiology
- Issue:
- Volume 89:Number 6(2013:Nov./Dec.)
- Issue Display:
- Volume 89, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 89
- Issue:
- 6
- Issue Sort Value:
- 2013-0089-0006-0000
- Page Start:
- 1479
- Page End:
- 1489
- Publication Date:
- 2013-09-10
- Subjects:
- Photochemistry -- Periodicals
Light -- Physiological effect -- Periodicals
541.35 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0031-8655&site=1 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/php.12147 ↗
- Languages:
- English
- ISSNs:
- 0031-8655
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6465.985000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 420.xml